Genomic landscape of extended-spectrum β-lactamase resistance in Escherichia coli from an urban African setting. by Musicha, Patrick et al.
Musicha, P; Feasey, NA; Cain, AK; Kallonen, T; Chaguza, C; Peno,
C; Khonga, M; Thompson, S; Gray, KJ; Mather, AE; Heyderman,
RS; Everett, DB; Thomson, NR; Msefula, CL (2017) Genomic land-
scape of extended-spectrum -lactamase resistance in Escherichia coli
from an urban African setting. The Journal of antimicrobial chemother-
apy. ISSN 0305-7453 DOI: https://doi.org/10.1093/jac/dkx058
Downloaded from: http://researchonline.lshtm.ac.uk/3682756/
DOI: 10.1093/jac/dkx058
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
Genomic landscape of extended-spectrum b-lactamase resistance in
Escherichia coli from an urban African setting
Patrick Musicha1–3*, Nicholas A. Feasey1,4, Amy K. Cain1,4, Teemu Kallonen5, Chrispin Chaguza1,3, Chikondi Peno1,
Margaret Khonga2, Sarah Thompson1†, Katherine J. Gray1‡, Alison E. Mather6, Robert S. Heyderman1,7,
Dean B. Everett1,3, Nicholas R. Thomson5,8§ and Chisomo L. Msefula1,2§
1Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Queen Elizabeth Central Hospital, Blantyre, Malawi; 2Microbiology
Unit, Department of Pathology, College of Medicine, University of Malawi, Blantyre, Malawi; 3Institute of Infection and Global Health,
University of Liverpool, Liverpool, UK; 4Liverpool School of Tropical Medicine, Liverpool, UK; 5Wellcome Trust Sanger Institute, Wellcome
Trust Genome Campus, Hinxton, UK; 6Department of Veterinary Medicine, University of Cambridge, Cambridge, UK; 7Division of
Infection and Immunity, University College London, London, UK; 8Department of Infectious and Tropical Diseases, London School of
Hygiene and Tropical Medicine, London, UK
*Corresponding author. Tel: !265-1-876444; Fax:!265-1-875774; E-mail: Patrick.Musicha@liverpool.ac.uk
†Present address: Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
‡Present address: Lancashire Teaching Hospitals NHS Foundation Trust, Lancashire, UK.
§These authors contributed equally to this work.
Received 30 August 2016; returned 7 November 2016; revised 11 January 2017; accepted 1 February 2017
Objectives: Efforts to treat Escherichia coli infections are increasingly being compromised by the rapid, global
spread of antimicrobial resistance (AMR). Whilst AMR in E. coli has been extensively investigated in resource-rich
settings, in sub-Saharan Africa molecular patterns of AMR are not well described. In this study, we have begun to
explore the population structure and molecular determinants of AMR amongst E. coli isolates from Malawi.
Methods: Ninety-four E. coli isolates from patients admitted to Queen’s Hospital, Malawi, were whole-genome
sequenced. The isolates were selected on the basis of diversity of phenotypic resistance profiles and clinical
source of isolation (blood, CSF and rectal swab). Sequence data were analysed using comparative genomics and
phylogenetics.
Results: Our results revealed the presence of five clades, which were strongly associated with E. coli phylogroups
A, B1, B2, D and F. We identified 43 multilocus STs, of which ST131 (14.9%) and ST12 (9.6%) were the most com-
mon. We identified 25 AMR genes. The most common ESBL gene was blaCTX-M-15 and it was present in all five
phylogroups and 11 STs, and most commonly detected in ST391 (4/4 isolates), ST648 (3/3 isolates) and ST131
[3/14 (21.4%) isolates].
Conclusions: This study has revealed a high diversity of lineages associated with AMR, including ESBL and fluoro-
quinolone resistance, in Malawi. The data highlight the value of longitudinal bacteraemia surveillance coupled
with detailed molecular epidemiology in all settings, including low-income settings, in describing the global epi-
demiology of ESBL resistance.
Introduction
In Africa, Escherichia coli is the second most common Gram-
negative cause of community-acquired bloodstream infection, ac-
counting for 7.3% of all confirmed bloodstream infection isolates,1
and is also one of the leading causes of diarrhoeal disease, which is
responsible for .10.0% of all deaths globally in children
under 5 years old, and.11.0% in Africa.2,3 E. coli is rapidly becom-
ing resistant to first-line and last-resort antimicrobial agents,
including cephalosporins, fluoroquinolones and, in some settings,
carbapenems,4–7 resulting in infections that are difficult or impos-
sible to treat depending on local availability of antimicrobials. The
spread of antimicrobial resistance (AMR) has often been attributed
to selective pressure resulting from increased use of antimicrobial
agents.8 In most developing countries, the high burden of invasive
bacterial infection, the high prevalence of immune-suppressive
conditions (e.g. malnutrition and HIV) and lack of diagnostic
VC The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
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microbiology facilities necessitates the widespread use of broad-
spectrum antimicrobials. In Malawi, high levels of cephalosporin
and fluoroquinolone resistance in E. coli strains have been reported
following extensive use of ceftriaxone and ciprofloxacin.9
Cephalosporin- and fluoroquinolone-resistant E. coli have also
been reported from a number of other countries in sub-Saharan
Africa (SSA).10–12
The main mechanism of cephalosporin resistance is drug in-
activation, which is mediated by hydrolysis of the b-lactam ring
of the antimicrobial agent by ESBL enzymes. CTX-M derivatives,
and in particular CTX-M-15, are now the dominant and most
widely disseminated ESBL type found amongst E. coli isolates.7
Furthermore, despite the high genetic diversity associated with
the E. coli species,13 ESBLs, especially of the CTX-M type, are
strongly associated with specific clonal E. coli lineages.8 In the
case of CTX-M-15, it is predominantly associated with a globally
disseminated ST131 clone.8,14 The ESBL-producing lineages are
also associated with fluoroquinolone resistance15 despite
being mediated by different mechanisms. Unlike cephalosporin
resistance, fluoroquinolone resistance is mainly conferred by
chromosomal mutations in the quinolone-binding target genes,
such as the subunits of the gyrase genes gyrA or gyrB and topo-
isomerase IV genes parC or parE.16 Plasmid-mediated genes
such as qnr, qep and aac(60)-Ib-cr have also been shown to con-
fer low-level fluoroquinolone resistance.16
WGS has emerged as an essential tool in understanding the
emergence and spread of resistant strains and therefore informing
strategies to combat AMR. Whilst the emergence of ESBL and
fluoroquinolone resistance in SSA is a major public health concern,
there are limited studies to provide genomic insight into the molecu-
lar patterns underlying the spread of ESBL and fluoroquinolone re-
sistance in the region. To our knowledge, we carried out this first E.
coliWGS study in Malawi to provide a baseline for understanding the
genetic population structure of clinical isolates of E. coli and identify
E. coli lineages associated with ESBL resistance in this setting.
Materials and methods
Ethics
The Malawi-Liverpool-Wellcome Trust Clinical Research Programme (MLW)
routine culture surveillance, under which the isolates were obtained, was
approved by the College of Medicine Research Ethics Committee (COMREC)
of the University of Malawi, approval number P.08/14/1614.
Study setting and sample collection
We used samples collected as part of routine bacteraemia and meningi-
tis surveillance undertaken at Queen Elizabeth Central Hospital (QECH),
Blantyre, Malawi, and archived at MLW. QECH is the largest government
hospital in Malawi, serving Blantyre (population 1.3 million) and the
surrounding districts. Adults had blood sampled for culture when admit-
ted to QECH with fever (axillary temperature .37.5C) or clinical evi-
dence of sepsis.17 CSF samples were taken from the adult patients
where there was clinical suspicion of meningitis.18 Blood or CSF samples
were taken from children with febrile illness, but who were malaria slide
negative and had no obvious focus of infection, or who were severely ill
with sepsis or meningitis, and patients who failed initial malaria treat-
ment and remained febrile.19 Antimicrobial susceptibility tests were
performed by the disc diffusion method using methods and breakpoints
outlined by BSAC (www.bsac.org.uk). Isolates were tested against six
commonly used antimicrobial agents, namely ampicillin, co-
trimoxazole, chloramphenicol, gentamicin, cefpodoxime and cipro-
floxacin. Isolates were stored on beads at#80C.
Isolate selection and DNA extraction
Sixty blood culture and 26 CSF E. coli isolates were selected from the MLW
archives on the basis of diversity of phenotypic resistance profiles and clin-
ical source of isolation. Isolates originated from paediatric (,16 years old)
and adult (16 years old) patients from the period 1996–2014. Eight rectal
swab isolates, all from 2009, were also included. Whole-genome DNA ex-
traction for selected isolates was done at MLW laboratories using the
Qiagen Universal Biorobot (Limburg, the Netherlands), following the manu-
facturer’s instructions.
WGS, de novo assembly and sequence annotation
Genomic DNA libraries were prepared and sequenced at the Wellcome
Trust Sanger Institute (WTSI) in Hinxton, UK, using the Illumina Hiseq 2000
platform (Illumina, Inc., San Diego, CA, USA). This generated paired-end se-
quence reads of 100 bp. The sequence reads were trimmed and checked
for quality using an average base pair quality score of at least 20 per read.
We used Velvet v1.2.09,20 a de novo sequence assembly method that uses
the De Bruijn graph approach to generate contiguous sequences (contigs)
by selecting the optimal k-mers using VelvetOptimiser.21 Assembled con-
tigs with,300 bp were excluded from the dataset and the remaining con-
tigs were scaffolded using SSPACE Basic v2.0.22 The gaps between contigs
were filled by GapFiller v1.10.23 Sequence assemblies were annotated using
the Prokka v1.11 bacterial annotation pipeline.24 Sequence reads were de-
posited in the European Nucleotide Archive (ENA). Isolate accession num-
bers, sequencing and assembly statistics are included in Table S1 (available
as Supplementary data at JACOnline).
Phylogeny reconstruction and inference of
population structure
The Roary pan-genome pipeline25 was used to construct the core genome
of the 94 E. coli strains using the annotated genome assemblies. Genes
were classified as ‘core’ if they were identified in at least 99% of the isolates.
All genes present in ,99% of the isolates were classified as ‘accessory’.
We aligned each core gene and concatenated all the alignments to gener-
ate a single core-gene multiple sequence alignment, which was used to
construct a maximum likelihood (ML) phylogenetic tree using RAxML
v.7.8.6.26 RAxML was run under the General Time Reversible (GTR) substitu-
tion model with a Gamma rate of correction heterogeneity. The reliability of
the inferred branches and branch partitions in the phylogenetic tree were
assessed using 100 bootstrap replicates.
To determine the underlying genomic population structure of the study
isolates, we mapped the sequence reads for all 94 isolates onto the E. coli
strain K12 sub-strain MG1655 reference whole-genome sequence (acces-
sion number U00096) using Burrows Wheeler Aligner (BWA).27 Realignment
of the insertion and deletion (indel) sites in the generated binary alignment
map (BAM) files for the isolates was performed using GATK v3.3.0.28 The con-
sensus pseudo-sequences were generated from each BAM file and aligned
with other sequences to generate whole-genome alignment of the study
isolates. We adjusted for recombination and used Gubbins29 to remove re-
combination sites from the whole-genome alignment and then generated
an alignment of polymorphic (variable) sites only using SNP-Sites.30 An ML
phylogenetic tree was then reconstructed using this SNP alignment, again
using RAxML with the same parameters used to construct the core-gene
alignment tree. Topologies of the core-gene alignment tree and mapping
(to reference) alignment SNP tree were compared by a tanglegram drawn
with a dendroscope.31 This SNP alignment was also used to cluster the iso-
lates into unique subpopulations or sequence clusters (SCs) using the
Population structure and AMR of E. coli from Malawi JAC
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hierBAPS module in the Bayesian analysis of population structure (BAPS)
v6.0 software.32
In silico molecular typing of study isolates
We did in silico MLST33 and PCR to determine the STs and phylogroups of
study isolates. MLST was performed using seven housekeeping genes,
namely adk, fumC, gyrB, icd,mdh, purA and recA (http://mlst.warwick.ac.uk/
mlst/dbs/Ecoli). For phylogroup typing, a two-stage in silico quadruplex PCR
was performed as described previously by Clermont et al.34 In brief, the first
stage of the PCR used four primers: arpA, chuA, yjaA and TspE.C2. If a given
isolate’s phylogroup could not be resolved from the first stage, a second
stage was performed that included two more primer sequences, trpAgpC
and arpAgpC.
Determination of antimicrobial resistance and
plasmid typing
Acquired AMR genes were searched for by BLAST,35 using a database of
acquired AMR genes curated at WTSI based on the ResFinder database.36
Presence of a gene in an isolate was confirmed if its assembled genome se-
quence had at least 95% nucleotide identity match with a gene in the data-
base and a coverage of at least 90% of the length of the database match.
We analysed translated nucleotide sequence alignments of the gyrA, gyrB,
parC and parE genes to identify specific amino acid mutations that were
associated with fluoroquinolone resistance. In silico plasmid typing was
done by searching for plasmid replicons against the PlasmidFinder
database.37
Statistical analyses
Proportions were compared using Fisher’s exact test or the v2 test where
appropriate and means of pairwise SNP differences for identified clades
were compared using one-way analysis of variance (ANOVA). We used the
power-law regression equation to model the expansion of the pan-
genome in relation to number of isolates. All statistical analyses were done
using R v3.3.1 (R Core Team, www.r-project.org).
Results
Pan-genome of Malawian E. coli isolates
Ninety-four E. coli strains were sequenced and included for com-
parative genomic analysis. Automated annotation predicted an
average of 4845 genes per isolate, which resulted in an overall pan-
genome consisting of 22 934 genes. Genes were considered to be
the same if they were identical in at least 95% of the nucleotide pos-
itions. The core gene set comprised 2210 genes, which is equivalent
to 9.6% of the pan-genome size and 45.6% of the average whole
genome size, while the accessory gene set consisted of 20 724
genes, i.e. 90.4% of the pan-genome size. The cumulative number
of genes in the pan-genome, the number of core genes per subset
of isolates, the number of isolate-specific (unique) genes per subset
of isolates and the number of newly identified genes when more
genomes were added to the collection were identified (Figure S1).
The pan-genome analysis has shown that the E. coli population in
Blantyre, Malawi, has an open pan-genome (Figure S2), consistent
with previous studies.38,39 This implies that the pan-genome will
continue to expand with the inclusion of more genome sequences.
The majority of the newly discovered genes with an increasing num-
ber of isolates were unique (Figure S1) and approximately one-third
of the total accessory genes consisted of strain-specific genes.
Sequence types and phylogroups
The degree of sequence diversity in the study isolates was further
analysed using MLST and phylogrouping. Our results from MLST
showed that the E. coli isolates belonged to 45 different STs. Seven
of the isolates could not be uniquely typed by MLST. ST131 was the
most common ST, identified in 14.9% (14/94) of the isolates, and
was followed by ST12, which was present in 9.6% (9/94) of the iso-
lates. Other common STs included ST69 (5.0%), ST10 (5.0%) and
ST391 (4.0%). Overall, a total of five phylogroups, namely A, B1, B2,
D and F, were identified in the study isolates. Phylogroup B2, which
was predominantly composed of ST131 and ST12 isolates, was the
largest phylogroup in this collection (Figure 1a), containing 34.0%
(32/94) of the isolates. Phylogroup A was the second largest phy-
logroup with 23.4% (22/94) isolates.
Population structure of Malawian E. coli isolates
A population structure analysis using the hierBAPS sequence-
clustering approach clustered the 94 E. coli isolates into five clades
or SCs designated SC1–SC5. The inferred SCs correlated with the
E. coli phylogroups described in the previous section (Figure 1a). The
SCs showed significant differences in nucleotide sequence diversity
(P,0.001) as demonstrated by the distribution of pairwise SNP dif-
ferences in each cluster (Figure 1b). The phylogeny reconstructed
from the core genome was compared with that reconstructed from
whole-genome sequence data adjusted for recombination, and this
revealed a similar topology (Figure S3). The phylogenetic clades
inferred from the core-genome ML phylogenetic tree were also con-
sistent with the hierBAPS clusters. SC2 and SC5 showed the lowest
within-cluster sequence diversity, characterized by short phylogen-
etic branches and lower average pairwise SNP differences of 1419
and 12 300 core-genome SNPs, respectively. In comparison, SC1,
SC3 and SC4 demonstrated higher average pairwise SNP differences
of 29 010, 22 230 and 23 950 core-genome SNPs, respectively
(Figure 1b). The highly divergent clusters, namely SC1, SC3 and SC4,
comprised diverse sets of STs, i.e. 9 STs in SC1, 23 STs in SC3 and 6
STs in SC4; the less diverse SCs, namely SC2 and SC5, on the other
hand, were principally associated with ST131 and ST12. Except for
SC5, which comprised blood culture isolates only (Figure 2), there
was generally no clustering of isolates specific to either source of
isolation or patients’ age group.
To understand the Malawian ST131 isolates in the context of
other global isolates, we mapped the 14 Malawian ST131
genomes and selected 17 previously published ST131 genomes
(from all three identified ST131 clades)40 to the ST131 EC958 refer-
ence genome and generated an ML phylogeny from
recombination-free SNP alignment. Two CTX-M-15 isolates from
Malawi (B28 and C4) clustered with isolates from the CTX-M-15-
associated sub-clade C, whereas one CTX-M-15 isolate (BKQ8AN)
clustered with the rest of the other Malawian non-CTX-M-15 iso-
lates into a sub-clade that we have designated D, which was dis-
tinct from the previously known sub-clades A, B and C (Figure 1c).
Genetic determinants of antimicrobial resistance in E. coli
Our analysis identified a total of 25 unique AMR genes known to
encode proteins conferring resistance to a range of different
classes of antimicrobial compounds, including aminoglycosides,
b-lactams, chloramphenicol, sulphonamides, trimethoprim,
Musicha et al.
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tetracyclines and fluoroquinolones (Table 1). AMR genes, especially
those present in at least four isolates, were distributed across the
E. coli phylogeny independent of phylogenetic clustering of the
host isolates (Figure 2). Similar to phylogenetic clustering, there
were no specific AMR genotypes associated with isolates from a
particular source or patient age group.
b-Lactam and ESBL resistance
We identified seven genes associated with b-lactam resist-
ance, including three ESBL genes (Table 1). Narrow-spectrum
b-lactamases included blaTEM-1 (74/94 isolates), blaOXA-1 (20/94
isolates), blaSCO-1 (2/94 isolates) and blaSHV-1 (1/94 isolates).
Twenty-one out of 94 (22.3%) isolates carried at least one ESBL
gene, of which blaCTX-M-15 was the most common (Table 1), being
present in 20/21 (95.2%) of the isolates carrying an ESBL gene.
The blaCTX-M-15 gene was significantly associated with resistance
to cephalosporins (P,0.001), with 19/20 isolates carrying the
bla-CTX-M-15 gene being resistant to ceftriaxone by disc testing. The
ceftriaxone resistance phenotype was not known for the remain-
ing isolate with the blaCTX-M15 gene. Other ESBLs detected included
blaSHV-12 (one isolate) and blaOXA-10 (one isolate), and both isolates
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Figure 1. Genomic population structure and relatedness of E. coli isolates collected from Blantyre, Malawi. (a) Circular ML core-genome phylogenetic
tree of Malawian E. coli isolates rooted at mid-point of the longest branch separating the two most divergent isolates. The inner ring designates iden-
tified SCs by hierBAPS and the outer ring designates phylogroups identified by in silico PCR. (b) Distribution of pairwise SNP differences in each of the
five clades to demonstrate the variations in sequence diversity in each clade. (c) An ML phylogenetic tree, constructed from recombination-free SNP
alignment of Malawian ST131 isolates (red branches) in the context of previously published global ST131 isolates (black branches). This figure appears
in colour in the online version of JAC and in black and white in the printed version of JAC.
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had expressed phenotypic resistance to ceftriaxone. Similar to all
common AMR genes identified in this collection, the blaCTX-M-15
gene was present in isolates independent of phylogenetic cluster-
ing. The distribution of isolates carrying blaCTX-M-15 showed that the
gene was present in isolates from five identified phylogroups and
11 STs, most commonly ST391 (4/4 isolates), ST648 (3/3 isolates)
and ST131 [3/14 (21.4%) isolates] (Table 2). The blaCTX-M-15 genes
were found to be located in both the chromosome (5/20 isolates)
and plasmid DNA (15/20 isolates), but their location was always
downstream and adjacent to the ISEcp1 element.
Fluoroquinolone resistance
We translated the aligned nucleotide sequences of each gene into
protein sequences. The amino acid products of the gyrA gene align-
ment were highly conserved. However, we identified amino acid
substitutions at codon position 83 from serine (S) to leucine (L),
(S83L), in 17.0% (16/94) and serine (S) to alanine (A), (S83A), in 2.1%
(2/94) of the isolates, and also at codon position 87, which showed
a change from aspartic acid (D) to asparagine (N), (D87N), in 14.9%
(14/94) of the isolates. Fourteen isolates had mutations at both
codon positions 83 and 87 and all of them showed in vitro resistance
to ciprofloxacin, whereas two isolates had only one codon mutation
at position 83 and they were fluoroquinolone susceptible. In add-
ition to the identified fluoroquinolone mutations, we also identified
four isolates carrying the horizontally acquired plasmid-mediated
fluoroquinolone resistance gene qnrB. None of the four isolates car-
rying the qnrB gene had the gyrA fluoroquinolone resistance muta-
tions, but three isolates showed reduced susceptibility to
fluoroquinolones.
Aminoglycoside resistance
Six genes known to confer resistance to aminoglycosides were
identified in this dataset. These include strA and strB in 87/94
(92.6%) isolates, aac3-IIa in 37/94 (39.4%) isolates, aac(60)-Ib-cr in
18/94 (19.1%) isolates, aph3 in 15/94 (16.0%) isolates and aadA in
2/94 (2.1%) isolates (Table 1). Both aac3-IIa and aac(60)-Ib-cr
were associated with gentamicin as well as fluoroquinolone resist-
ance phenotypes (P,0.001). Together, strA and strB are known
to confer resistance to streptomycin, which is only used in Malawi
for re-treatment of TB, and there was no significant association
between these genes and gentamicin resistance phenotype
(P"0.318).
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Figure 2. Distribution of AMR phenotype profiles, acquired AMR genes and plasmid incompatibility groups across the phylogeny of Malawian E. coli
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Chloramphenicol resistance
Four genes known to encode chloramphenicol resistance were
identified: catA in 61/94 (64.9%) isolates; floR in 3/94 (3.2%) iso-
lates; catB in 2/94 (2.1%) isolates; and cmlA1 in 1/94 (1.1%) iso-
lates (Table 1). The in silico predictions were confirmed by
phenotypic resistance data, with chloramphenicol resistance being
strongly associated with the presence of the catA gene (P,0.001).
All three isolates carrying the floR gene had a chloramphenicol re-
sistance phenotype, whereas the isolate with the cmlA1 gene was
susceptible to chloramphenicol. The isolate with the catB gene
also had the catA gene and was chloramphenicol resistant.
Plasmid incompatibility groups
A search against the PlasmidFinder database identified a total of
15 different plasmid replicons (including FIA, FIB, FII, Col, A/C,
HI1B, HI2, B/O/K/Z, I2, Q, P, p0111, R, X4 and Y) to be present in our
collection of E. coli isolates (Figure 2). FIB, FIA and FII were the
most common plasmid replicons across all the 94 isolates
(Figure 2) but also amongst isolates that had the blaCTX-M-15 gene
(Table 2). One IncFIB plasmid was similar to pNDM-Mar1 (GenBank
accession number JN420336), a plasmid known to encode the car-
bapenem resistance gene blaNDM-1, although no carbapenem re-
sistance gene was identified in this dataset.
Discussion
E. coli is well known to be a highly diverse species13 that is strongly
associated with AMR. In this study, we whole-genome sequenced
94 E. coli isolates collected in Blantyre, Malawi, situated in a region
Table 1. Distribution of AMR genes among Malawian E. coli isolates
Gene Known AMR phenotype Isolates, n (%)
sul2 sulphonamides 88 (93.6)
strA aminoglycosides 87 (92.6)
strB aminoglycosides 87 (92.6)
dfrA trimethoprim 86 (91.5)
blaTEM-1 b-lactams 74 (78.7)
catA chloramphenicol 61 (64.9)
sul1 sulphonamides 51 (54.3)
tetB tetracycline 51 (54.3)
aac3-IIa aminoglycosides 37 (39.4)
tetA tetracycline 38 (40.4)
mphA macrolides 35 (37.2)
blaCTX-M-15 ESBL 20 (21.3)
blaOXA-1 b-lactams 20 (21.3)
aac(60)-Ib-cr aminoglycosides, fluoroquinolone 18 (19.1)
aph3 aminoglycosides 15 (16.0)
qnrB1 fluoroquinolones 4 (4.3)
floR chloramphenicol 3 (3.2)
blaSCO-1 b-lactams 2 (2.1)
aadA2 aminoglycosides 2 (2.1)
blaSHV-12 ESBL 2 (2.1)
catB chloramphenicol 2 (2.1)
cmlA1 chloramphenicol 1 (1.1)
blaOXA-10 ESBL 1 (1.1)
blaSHV-1 b-lactam 1 (1.1)
qepA quinolones 1 (1.1)
Table 2. Characteristics of Malawian CTX-M-15-associated E. coli isolates
Isolate ID Year of isolation Source ST Phylogroup Genome locus Plasmid replicon
D42544 2007 blood 1084 D plasmid FIB, FII, HI2
BKQA8N 2013 blood 131 B2 chromosome FIB, FII, HI2, P, Q1
C4 — CSF 131 B2 chromosome Col, FIA, FIB, Q1
B28 2009 RS 131 B2 chromosome Col, FIA, FII, X4, Y
C30 2009 RS 167 A plasmid FIA, FIB, FII, I2, Y
C33b — CSF 167 A plasmid FIA, FIB, FII, I2, P, Y
1012184 2011 blood 361 A plasmid FIB, FII
D40034 2006 blood 391 D plasmid FIB, FIA, X1
BKQ5JN 2013 blood 391 D plasmid FIB, FIA, X1, X4
D40059A 2006 blood 391 D plasmid FIA, FIB, X1
C14 — CSF 391 D plasmid A/C, FIA, FIB, FII, Q1
A1a 2009 RS 399 A plasmid HI2, Y
A16 2009 blood 448 B1 plasmid A/C, FIA, FIB, FII, Q1
A3b 2009 RS 617 A plasmid FIA, FIB, FII
A27 2009 RS 648 F chromosome FIA, FIB, FII
C15 — CSF 648 F chromosome FIA, FIB, FII
C20b 2009 RS 648 F chromosome Col, FIA, FIB, FII
1016948 2011 CSF 977 B1 plasmid Y
1014142 2011 blood 1163 F plasmid FIA, FIB, FII, Q1, Y
RS, rectal swab.
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from which such data are severely lacking. We reveal that E. coli in
this setting has an expanding pan-genome, and high diversity in
phylogenetic clustering, STs and phylogroups consistent with the
known global diversity. Furthermore, we demonstrate that AMR, in
particular ESBL resistance, in Malawi has emerged across a diverse
range of E. coli lineages containing a number of similar resistance
genes.
The most commonly identified ESBL gene was blaCTX-M-15, pre-
sent in 11 STs and all five identified phylogroups, including all ST391
genomes, 3/14 ST131 genomes and a number of other clonally di-
verse STs (Table 2). Within SSA, a high diversity of CTX-M-15-associ-
ated STs has also been reported in Tanzania,11 whereas globally the
blaCTX-M-15 gene has been more strongly associated with a sub-
lineage of ST131, H30-Rx.41 The predominance of this ST131 sub-
lineage as a CTX-M-15 clone has been reported in Asia, Europe,
North Africa and South America.7,42–45 Further work is required in
Malawi to accurately estimate the prevalence of blaCTX-M-15 across
the different clades causing drug-resistant infection.
ST131 isolates in this study constitute the most clonal SC in the
population structure of our collection, suggesting that they were
the most recent lineage to emerge or arrive in this setting. A previ-
ous study of a global collection of ST131 isolates identified three
sub-lineages of the ST131 isolates, which were designated A, B
and C.40 When put in the context of these global ST131 isolates,
the majority of the Malawian ST131 isolates form a sub-lineage
distinct from these previously identified sub-lineages (Figure 1c).
Furthermore, whilst two of the three CTX-M-15 isolates from
Malawi cluster in the CTX-M-15-associated sub-lineage C, one clus-
ters with the rest of the other Malawian isolates in sub-clade D. The
CTX-M-15-associated ST131 clone is reported to have emerged in
the early to mid 2000s7 and has since spread in a series of clonal ex-
pansions to become the most dominant E. coli clone, causing a
spectrum of extra-intestinal infections, including urinary tract infec-
tions, bacteraemia, pneumonia, and intra-abdominal and wound
infections.44 In our collection, the earliest CTX-M-15-associated
ST131 isolate was isolated in 2009, and although the CTX-M-15
ST131 clone might have emerged earlier in this setting, a previous
study of ESBL-producing Enterobacteriaceae in 2004–05 did not
identify CTX-M-15-producing E. coli.46 It is therefore likely that CTX-
M-15-associated ST131 emerged or arrived in this setting a few
years after its emergence in Europe and North America.
In this study, we have further shown that the blaCTX-M-15 gene
exists in genetically heterogeneous strains even within the ST131
lineage (Figure 1a and c). It is not only the case that blaCTX-M-15 was
distributed across phylogenetically diverse isolates, but fluoro-
quinolone resistance genotypes and all other common AMR genes,
including dfrA, sul1, sul2, strA, strB, blaTEM-1, catA and tetB, were
also widely distributed. The set of common AMR genes, namely
dfrA, sul1, sul2, strA, strB, blaTEM-1, catA and tetB, has previously
been characterized in MDR Salmonella circulating in Blantyre but,
unlike with E. coli, these were associated with epidemic clades.47,48
In conclusion, this study has revealed a high diversity of lin-
eages of E. coli circulating in Malawi and associated with AMR,
including ESBL and fluoroquinolone resistance. Further work is
required to ascertain which clades are the predominant cause of
drug-resistant infection in this setting. The data highlight the value
of longitudinal bacteraemia surveillance coupled with detailed
molecular epidemiology in all settings in describing the global epi-
demiology of ESBL resistance.
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